Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Jazz Pharma Earnings Top Estimates As Xyrem Ramps
Investors.com
Thursday, November 8, 2012 - 10:19pm
tags:
Jazz Pharmaceuticals, earnings
Mylan To Wall Street: Forget Patent Cliff, We'll Grow
Investors.com
Thursday, November 8, 2012 - 9:54pm
tags:
Mylan, patents, generics, Teva, Watson Pharmaceuticals
FDA panel recommends approval of Novo degludec insulin
Reuters
Thursday, November 8, 2012 - 9:52pm
tags:
FDA, advisory panels, Novo Nordisk, degludec, insulin
Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.
NASDAQ.com
Thursday, November 8, 2012 - 12:08pm
tags:
Sun Pharma, DUSA pharmaceuticals, M&A, India
ImmunoGen Is Living Life in the Fast Lane
Motley Fool
Thursday, November 8, 2012 - 12:07pm
tags:
Immunogen, Roche, T-DM1, breast cancer
Amicus Therapeutics Poised For Rebound Into December Phase III Results
Seeking Alpha
Thursday, November 8, 2012 - 12:05pm
tags:
Amicus Therapeutics, GSK, Amigal
3 Stocks With High Alphas: Acadia, Hemispherx, And Vringo
Seeking Alpha
Thursday, November 8, 2012 - 12:04pm
tags:
Acadia, Hemispherx Biopharma
Think Of Pfizer As A Cigarette Company
Seeking Alpha
Thursday, November 8, 2012 - 12:03pm
tags:
Pfizer
POZEN Reports Third Quarter 2012 Financial Results and Positive PA32540 Clinical Updates
Yahoo
Thursday, November 8, 2012 - 11:13am
tags:
earnings, Pozen
What Orexigen Is Saying -- and Not Saying
Motley Fool
Thursday, November 8, 2012 - 11:00am
tags:
Orexigen, obesity, Contrave, Arena Pharmaceuticals, Vivus
Canada top court rules against Pfizer in Viagra case
Reuters
Thursday, November 8, 2012 - 10:59am
tags:
Canada, Pfizer, Viagra, patents, erectile dysfunction, Teva
Novartis says expects to have 14 new blockbusters by 2017
Reuters
Thursday, November 8, 2012 - 10:57am
tags:
Novartis, LCZ696, serelaxin
AstraZeneca, PTSD And A Buried Seroquel Study
Pharmalot
Thursday, November 8, 2012 - 10:54am
tags:
PTSD, AstraZeneca, Seroquel
Auxilium Falls Most in Year as Pfizer Deal Ends
Bloomberg
Thursday, November 8, 2012 - 10:53am
tags:
Pfizer, Auxilium, Xiapex, Dupuytren's Contracture
Ariad's on the Launchpad
Motley Fool
Thursday, November 8, 2012 - 10:51am
tags:
Ariad Pharmaceuticals, earnings
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Yahoo
Thursday, November 8, 2012 - 10:51am
tags:
M&A, EpiCept, Immune Pharmaceuticals
Vical's Allovectin: Update On The Phase III Trial
Seeking Alpha
Thursday, November 8, 2012 - 10:50am
tags:
Vical, Allovectin, Bristol-Myers Squibb, JNJ, melanoma
India's Ranbaxy beats estimates on higher sales, forex gain
Reuters
Thursday, November 8, 2012 - 10:49am
tags:
Ranbaxy, India, earnings
NeoStem To Create Value With Billion Dollar Potential
Seeking Alpha
Wednesday, November 7, 2012 - 12:39pm
tags:
NeoStem, Neuralstem, Osiris, StemCells
Amyris Advances Most in Two Weeks After Reporting Narrower Loss
Bloomberg
Wednesday, November 7, 2012 - 12:37pm
tags:
Amyris

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.